Patents by Inventor Rainer Mussmann

Rainer Mussmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10488332
    Abstract: A device for determining a dirt load in a rinsing or detergent solution in a water-conducting household appliance includes a sensor configured to execute a near-infrared spectroscopy for acquiring a spectral measured value of a dirt component in the rinsing or detergent solution in the water-conducting household appliance. A determination unit determines the dirt load of the rinsing or detergent solution on the basis of the acquired spectral measured value of the dirt component in the rinsing or detergent solution, and an adjustment unit adjusts a wash parameter of a current wash program in response to the determined dirt load.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: November 26, 2019
    Assignees: BSH Hausgeräte GmbH, Henkel AG & Co. KGaA
    Inventors: Arnd Kessler, Edith Lambert, Nina Mußmann, Rainer Stamminger, Thomas Weber, Michaela Gerstenlauer, Heinz Heißler, Martin Stickel
  • Publication number: 20160060317
    Abstract: The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability.
    Type: Application
    Filed: April 8, 2015
    Publication date: March 3, 2016
    Inventors: Matthias Austen, Marcus Geese, Rainer Mussmann, Friedrich Harder, Thomas Siegmund, Martin Schneider
  • Patent number: 9029323
    Abstract: The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability.
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: May 12, 2015
    Assignee: Evotec International GmbH
    Inventors: Matthias Austen, Marcus Geese, Rainer Mussmann, Friedrich Harder, Thomas Siegmund, Martin Schneider
  • Publication number: 20130231283
    Abstract: The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability.
    Type: Application
    Filed: February 1, 2013
    Publication date: September 5, 2013
    Applicant: DeveloGen Aktiengesellschaft
    Inventors: Matthias Austen, Marcus Geese, Rainer Mussmann, Friedrich Harder, Thomas Siegmund, Martin Schneider
  • Patent number: 7968535
    Abstract: This invention relates to the use of azapaullones, particularly in combination with immunomodulating agents, in the prevention, and/or treatment of pancreatic autoimmune disorders, e.g. type I diabetes or LADA and neurodegenerative disorders.
    Type: Grant
    Filed: May 4, 2006
    Date of Patent: June 28, 2011
    Assignees: Develogen Atkiengesellschaft, Technische Universitaet Carolo-Wilhelmina Zu Braunschweig
    Inventors: Rainer Mussmann, Conrad Peter Kunick, Hendrik Stukenbrock, Marcus Geese, Simone Kegel, Ulrike Burk
  • Publication number: 20110003741
    Abstract: The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability.
    Type: Application
    Filed: May 5, 2010
    Publication date: January 6, 2011
    Applicant: DEVELOGEN AKTIENGESELLSCHAFT
    Inventors: Matthias Austen, Marcus Geese, Rainer Mussmann, Friedrich Harder, Thomas Siegmund, Martin Schneider
  • Publication number: 20080287423
    Abstract: This invention relates to the use of azapaullones, particularly in combination with immunomodulating agents, in the prevention, and/or treatment of pancreatic autoimmune disorders, e.g. type I diabetes or LADA and neurodegenerative disorders.
    Type: Application
    Filed: May 4, 2006
    Publication date: November 20, 2008
    Inventors: Rainer Mussmann, Conrad Peter Kunick, Hendrik Stukenbrock, Marcus Geese, Simone Kegel, Ulrike Burk
  • Publication number: 20080207594
    Abstract: This invention relates to the use of Pax4 stimulating compounds, e.g. Glycogen synthase kinase-3 (GSK-3) inhibitors, particularly in combination with immunomodulating agents, in the prevention, and/or treatment of pancreatic autoimmune disorders, e.g. type I diabetes or LADA. More particularly, this invention relates to the use of compounds selected from paullones, indirubines, substituted ureas, maleimide derivatives and pyrimidine thiones. Further, the present invention relates to a method of identifying and/or characterizing pancreatic beta-cell mitogens by using cells expressing a pancreatic gene or a gene whose function is controlled by a pancreatic gene, particularly the Pax4 gene, and which are transfected with a reporter gene.
    Type: Application
    Filed: May 4, 2006
    Publication date: August 28, 2008
    Applicant: Davelogen Aktiengesellschaft
    Inventors: Rainer Mussmann, Matthias Austen, Arndt-Rene Kelter, Friedrich Harder, Babette Aicher, Alexander Lomow